Declining Incidence Rates of Distal Symmetric Polyneuropathy in People With Type 1 and Type 2 Diabetes in Denmark, With Indications of Distinct Patterns in Type 1 Diabetes

Diabetes CarePublished Population-based cohort study

Authors' conclusion

Incidence rates for DSPN are declining in type 1 and type 2 diabetes, possibly due to improved diabetes treatment. This causality remains to be explored. Distinct age-related patterns indicate that the pathophysiology of DSPN may differ between diabetes types.

Study context

Population
Individuals with T1D or T2D at a Danish tertiary diabetes center, 1996–2018, without prevalent distal symmetric polyneuropathy (DSPN); vibration perception threshold by biothesiometry9,473 analysed (>25 V)
Participants
19,342 individuals
Exposure
DSPN incidence by calendar time, T1D and T2D
Outcome
Incidence rate of DSPN (vibration perception threshold >25 V; also age-, sex- and height-specific cutoff)
Follow-up
1996 to 2018
Methodological detailssingle tertiary diabetes centre, Poisson regression
  • Single tertiary diabetes centre
  • Poisson regression

Main finding

As reported in the abstract

DSPN incidence rate (>25 V cutoff), 1996 to 2018

40-year-old men with T1D: 1996 → 2018, per 100 PY

4.78 (3.60-6.33) → 1.15 (0.91-1.47) (95% CI)

60-year-old men with T2D: 1996 → 2018, per 100 PY

16.54 (11.80-23.18) → 8.02 (6.63-9.69) (95% CI)

Observational data: associations, not effects.

Further findings

DSPN incidence with age-, sex- and height-specific cutoff

Similar incidence patterns by calendar time without sex differences
  • 2,783 analysed

DSPN incidence by age in T1D

Decreasing incidence rates with older age in T1D

Original publication

Declining Incidence Rates of Distal Symmetric Polyneuropathy in People With Type 1 and Type 2 Diabetes in Denmark, With Indications of Distinct Patterns in Type 1 Diabetes. Diabetes Care. Published 30 August 2023. doi:10.2337/dc23-0312

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.